Groups IP AA Oral AA
Gender (male/female) 8/8 12/8
Age (years) 58 ± 11.4 52.5 ± 12
Dialysis duration (months) 48 ± 46.9 41 ± 19.5
Kt/V 2.3 ± 0.6 2.1 ± 0.5
nPCR (g/kg/d) 0.91 ± 0.24 0.76 ± 0.16
Etiology
DM 4 4
HT 7 6
PCKD 0 1
GN 0 1
Unknown cause 5 8
Residual Renal Function (Yes/No) 14/2 18/2
PET permeability test
Low-medium 5 8
Low 1 1
High 3 2
High-medium 7 9
Table 2: Characteristics of Patients Receiving Amino Acid (AA) Replacement.